NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Enlivex Therapeutics Ltd (TA: ENLV)

 
ENLV Technical Analysis
5
As on 12th Oct 2025 ENLV STOCK Price closed @ 367.60 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 480.56 & Strong Sell for SHORT-TERM with Stoploss of 548.43 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ENLVSTOCK Price

Open 370.00 Change Price %
High 378.50 1 Day -18.00 -4.67
Low 344.50 1 Week 25.00 7.30
Close 367.60 1 Month 6.20 1.72
Volume 72787 1 Year -203.00 -35.58
52 Week High 1537.00 | 52 Week Low 318.50
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
XTLB 4.80 -14.29%
BLRX 2.20 -4.35%
ELAL 1301.00 -1.96%
BEZQ 675.00 0.46%
ORL 93.50 -0.53%
MGDL 1138.00 -1.39%
TDGN-L 171.50 17.55%
LUMI 6420.00 -0.47%
DSCT 3280.00 0.99%
 
TA Israel Top Gainers Stocks
LPSN 2127.00 1400.00%
LPSN 2127.00 1400.00%
GLTC 130.00 21.50%
GLTC 130.00 21.50%
GLTC 130.00 21.50%
TDGN-L 171.50 17.55%
MCRNT 372.50 16.84%
SEFA 595.00 13.98%
SEFA 595.00 13.98%
NALA 595.00 13.98%
 
TA Israel Top Losers Stocks
KRNV 2.10 -34.38%
INSL 218.00 -27.09%
EFNC 218.00 -27.09%
KMNK 51.00 -23.19%
SCC 515.50 -16.77%
SCC 515.50 -16.77%
SCC 515.50 -16.77%
SCC 515.50 -16.77%
ULTR 74.10 -16.74%
XTLB 4.80 -14.29%
 
 
ENLV
Daily Charts
ENLV
Intraday Charts
Whats New @
Bazaartrend
ENLV
Free Analysis
 
ENLV Important Levels Intraday
RESISTANCE433.12
RESISTANCE412.11
RESISTANCE399.12
RESISTANCE386.13
SUPPORT349.07
SUPPORT336.08
SUPPORT323.09
SUPPORT302.08
 
ENLV Forecast October 2025
4th UP Forecast617.34
3rd UP Forecast537.25
2nd UP Forecast487.74
1st UP Forecast438.23
1st DOWN Forecast296.97
2nd DOWN Forecast247.46
3rd DOWN Forecast197.95
4th DOWN Forecast117.86
 
ENLV Weekly Forecast
4th UP Forecast695.19
3rd UP Forecast590.13
2nd UP Forecast525.19
1st UP Forecast460.25
1st DOWN Forecast274.95
2nd DOWN Forecast210.01
3rd DOWN Forecast145.07
4th DOWN Forecast40.01
 
ENLV Forecast2025
4th UP Forecast1087.53
3rd UP Forecast856.64
2nd UP Forecast713.93
1st UP Forecast571.21
1st DOWN Forecast163.99
2nd DOWN Forecast21.27
3rd DOWN Forecast-121.44
4th DOWN Forecast-352.33
 
 
ENLV Other Details
Segment EQ
Market Capital 50720083968.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ENLV Address
ENLV
 
ENLV Latest News
 
Your Comments and Response on Enlivex Therapeutics Ltd
 
ENLV Business Profile
Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. It is developing Allocetra, an off-the-shelf cell therapy designed to reprogram macrophages into homeostatic state. Resetting non-homeostatic macrophages into homeostatic state is critical for immune system rebalancing and resolution of life-threatening conditions. Diseases, such as solid cancers, sepsis, COVID-19, and others reprogram macrophages out of homeostatic state. Its Allocetra has the potential to provide a novel immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents. The company has a research collaboration with Yale Cancer Center for the assessment of Allocetra to enhance the activity of checkpoint inhibitors in solid tumors. Enlivex Therapeutics Ltd. was incorporated in 2005 and is headquartered in Nes Ziona, Israel. Address: 14 Einstein Street, Ness Ziona, Israel, 7403618
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service